These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1874 related items for PubMed ID: 15679715

  • 1. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.
    Humbert M, Beasley R, Ayres J, Slavin R, Hébert J, Bousquet J, Beeh KM, Ramos S, Canonica GW, Hedgecock S, Fox H, Blogg M, Surrey K.
    Allergy; 2005 Mar; 60(3):309-16. PubMed ID: 15679715
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of omalizumab in an Asian population with moderate-to-severe persistent asthma.
    Ohta K, Miyamoto T, Amagasaki T, Yamamoto M, 1304 Study Group.
    Respirology; 2009 Nov; 14(8):1156-65. PubMed ID: 19909462
    [Abstract] [Full Text] [Related]

  • 5. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma.
    Bousquet J, Cabrera P, Berkman N, Buhl R, Holgate S, Wenzel S, Fox H, Hedgecock S, Blogg M, Cioppa GD.
    Allergy; 2005 Mar; 60(3):302-8. PubMed ID: 15679714
    [Abstract] [Full Text] [Related]

  • 6. Effect of omalizumab as add-on therapy on asthma-related quality of life in severe allergic asthma: a Brazilian study (QUALITX).
    Rubin AS, Souza-Machado A, Andradre-Lima M, Ferreira F, Honda A, Matozo TM, QUALITX Study Investigators.
    J Asthma; 2012 Apr; 49(3):288-93. PubMed ID: 22356355
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with poorly controlled (moderate-to-severe) allergic asthma.
    Ayres JG, Higgins B, Chilvers ER, Ayre G, Blogg M, Fox H.
    Allergy; 2004 Jul; 59(7):701-8. PubMed ID: 15180756
    [Abstract] [Full Text] [Related]

  • 8. Add-on omalizumab improves day-to-day symptoms in inadequately controlled severe persistent allergic asthma.
    Humbert M, Berger W, Rapatz G, Turk F.
    Allergy; 2008 May; 63(5):592-6. PubMed ID: 18355388
    [Abstract] [Full Text] [Related]

  • 9. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P, Swenson C, Faiferman I, Matthews J, Williams M, Brannick L, Robinson D, Wenzel S, Busse W, Hansel TT, Barnes NC, International Mepolizumab Study Group.
    Am J Respir Crit Care Med; 2007 Dec 01; 176(11):1062-71. PubMed ID: 17872493
    [Abstract] [Full Text] [Related]

  • 10. Anti-IgE in severe persistent allergic asthma.
    Fox H.
    Respirology; 2007 Nov 01; 12 Suppl 3():S22-8; discussion S45-7. PubMed ID: 17956516
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR.
    Vignola AM, Humbert M, Bousquet J, Boulet LP, Hedgecock S, Blogg M, Fox H, Surrey K.
    Allergy; 2004 Jul 01; 59(7):709-17. PubMed ID: 15180757
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of omalizumab, an anti-immunoglobulin E antibody, in patients with allergic asthma at high risk of serious asthma-related morbidity and mortality.
    Holgate S, Bousquet J, Wenzel S, Fox H, Liu J, Castellsague J.
    Curr Med Res Opin; 2001 Jul 01; 17(4):233-40. PubMed ID: 11922396
    [Abstract] [Full Text] [Related]

  • 13. Omalizumab in children with inadequately controlled severe allergic (IgE-mediated) asthma.
    Kulus M, Hébert J, Garcia E, Fowler Taylor A, Fernandez Vidaurre C, Blogg M.
    Curr Med Res Opin; 2010 Jun 01; 26(6):1285-93. PubMed ID: 20377320
    [Abstract] [Full Text] [Related]

  • 14. Omalizumab in patients with severe persistent allergic asthma in a real-life setting in Germany.
    Korn S, Thielen A, Seyfried S, Taube C, Kornmann O, Buhl R.
    Respir Med; 2009 Nov 01; 103(11):1725-31. PubMed ID: 19515548
    [Abstract] [Full Text] [Related]

  • 15. Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis.
    Busse WW, Massanari M, Kianifard F, Geba GP.
    Curr Med Res Opin; 2007 Oct 01; 23(10):2379-86. PubMed ID: 17711616
    [Abstract] [Full Text] [Related]

  • 16. Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial.
    Hanania NA, Alpan O, Hamilos DL, Condemi JJ, Reyes-Rivera I, Zhu J, Rosen KE, Eisner MD, Wong DA, Busse W.
    Ann Intern Med; 2011 May 03; 154(9):573-82. PubMed ID: 21536936
    [Abstract] [Full Text] [Related]

  • 17. EXCEL: A randomised trial comparing salmeterol/fluticasone propionate and formoterol/budesonide combinations in adults with persistent asthma.
    Dahl R, Chuchalin A, Gor D, Yoxall S, Sharma R.
    Respir Med; 2006 Jul 03; 100(7):1152-62. PubMed ID: 16675212
    [Abstract] [Full Text] [Related]

  • 18. A 12-week, multicenter, randomized, partially blinded, active-controlled, parallel-group study of budesonide inhalation suspension in adolescents and adults with moderate to severe persistent asthma previously receiving inhaled corticosteroids with a metered-dose or dry powder inhaler.
    Murphy K, Noonan M, Silkoff PE, Uryniak T.
    Clin Ther; 2007 Jun 03; 29(6):1013-26. PubMed ID: 17692718
    [Abstract] [Full Text] [Related]

  • 19. Improvement in quality of life with omalizumab in patients with severe allergic asthma.
    Chipps B, Buhl R, Beeh KM, Fox H, Thomas K, Reisner C.
    Curr Med Res Opin; 2006 Nov 03; 22(11):2201-8. PubMed ID: 17076981
    [Abstract] [Full Text] [Related]

  • 20. An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma.
    Sullivan SD, Turk F.
    Allergy; 2008 Jun 03; 63(6):670-84. PubMed ID: 18445184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 94.